Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Differences between A7 antibody and anti-CEA antibody

S Kojima1, N Suzuki, K Kubota

  • 1Research Institute for Biosciences, Science University of Tokyo, Chiba, Japan.

Nuclear Medicine and Biology
|February 1, 1993
PubMed
Summary

A7 monoclonal antibody (MoAb) shows high specificity for colon cancer, concentrating in tumors more effectively than anti-CEA MoAb. This suggests A7 MoAb

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Elemental diet modulates the growth of Clostridium difficile in the gut flora.

Alimentary pharmacology & therapeutics·2004
Same author

Mutations to Gly2370, Gly2373 or Gly2375 in malignant hyperthermia domain 2 decrease caffeine and cresol sensitivity of the rabbit skeletal-muscle Ca2+-release channel (ryanodine receptor isoform 1).

The Biochemical journal·2001
Same author

Adaptive changes in dynamic properties of human disparity-induced vergence.

Investigative ophthalmology & visual science·2001
Same author

Regulation of serotonin transporter gene expression in human glial cells by growth factors.

European journal of pharmacology·2001
Same author

Age-related changes of glutathione content, glucose transport and metabolism, and mitochondrial electron transfer function in mouse brain.

Nuclear medicine and biology·2001
Same author

Effect of in vitro ischemic or hypoxic treatment on mitochondrial electron transfer activity in rat brain slices assessed by gas-tissue autoradiography using.

Brain research·2001

Area of Science:

  • Oncology
  • Immunology
  • Biotechnology

Background:

  • Monoclonal antibodies (MoAbs) are crucial for targeted cancer therapies.
  • Carcinogenic embryonic antigen (CEA) is a known biomarker for colon cancer.
  • Developing novel MoAbs with improved specificity is essential for effective cancer detection and treatment.

Purpose of the Study:

  • To evaluate the specificity and efficacy of A7 monoclonal antibody (MoAb) against human colon cancer.
  • To compare the performance of A7 MoAb with anti-CEA MoAb in vitro and in vivo.
  • To determine the potential of A7 MoAb for radioimmunodetection and treatment of colon cancer.

Main Methods:

  • Biodistribution studies of radiolabeled A7 MoAb and anti-CEA MoAb in tumor-bearing nude mice (colon, glioblastoma, lung).

Related Experiment Videos

  • In vitro binding assays of MoAbs with colon cancer (LS-174T) and glioblastoma cells.
  • Competitive binding assays to assess epitope specificity.
  • Radioimmuno-imaging studies to visualize tumors in vivo.

    • Main Results:

    • A7 MoAb demonstrated high concentration in LS-174T colon cancer and moderate uptake in glioblastoma.
    • Anti-CEA MoAb showed significant uptake only in LS-174T colon cancer.
    • A7 MoAb exhibited higher affinity for LS-174T cells than anti-CEA MoAb.
    • Competitive assays confirmed distinct binding sites for A7 MoAb and anti-CEA MoAb.
    • Radioimmuno-imaging clearly visualized both colon and glioblastoma tumors with A7 MoAb.

    Conclusions:

    • A7 MoAb exhibits distinct specificity and higher affinity for colon cancer compared to anti-CEA MoAb.
    • A7 MoAb shows potential for targeting both colon and glioblastoma tumors.
    • A7 MoAb is a promising candidate for in vivo radioimmunodetection and potential therapeutic applications in colon cancer.